The COH34 analog 1 is primarily utilized in the field of pharmaceutical research and development, particularly in the study of enzyme inhibition and metabolic pathways. It serves as a key compound in the investigation of therapeutic agents targeting specific enzymes involved in disease processes. Researchers employ this analog to explore its potential in modulating biological activities, which could lead to the development of novel treatments for conditions such as metabolic disorders or certain types of cancers. Additionally, its structural properties make it a valuable candidate for the design of more effective and selective drugs, enhancing the precision of therapeutic interventions.